porcin
epidem
diarrhea
viru
pedv
member
order
nidoviral
famili
coronavirida
genu
alphacoronaviru
caus
agent
porcin
epidem
diarrhea
ped
character
wateri
diarrhea
vomit
dehydr
growth
retard
high
morbid
mortal
suckl
piglet
pedv
envelop
singlestrand
positivesens
rna
viru
genom
approxim
kb
length
compos
seven
open
read
frame
four
structur
protein
name
spike
glycoprotein
membran
protein
envelop
e
protein
nucleocapsid
n
protein
one
accessori
protein
encod
among
structur
protein
protein
major
envelop
glycoprotein
respons
receptor
bind
cell
membran
fusion
entri
therefor
protein
consid
main
target
neutral
antibodi
pedv
frequent
use
phylogenet
analysi
establish
serolog
diagnost
method
develop
new
vaccin
sinc
pedv
outbreak
occur
asian
swine
herd
diseas
becom
widespread
ultim
endem
region
furthermor
new
highli
virul
pedv
strain
emerg
china
end
caus
larg
econom
loss
start
spring
pedv
variant
outbreak
success
report
unit
state
us
subsequ
spread
countri
north
america
europ
although
attenu
inactiv
pedv
vaccin
develop
wide
use
asia
mani
year
sever
pedv
outbreak
still
report
recent
year
main
reason
result
vaccin
base
european
classic
pedv
strain
fail
control
recent
virul
pedv
strain
asia
therefor
necessari
urgent
develop
new
pedv
vaccin
highli
virul
variant
viru
present
commerci
avail
vaccin
especi
asia
tradit
live
attenu
inactivatedkil
vaccin
efficaci
need
develop
improv
studi
therefor
mani
studi
carri
develop
nextgener
pedv
vaccin
base
protein
recombin
lactobacillu
vaccin
recombin
dna
plasmid
vaccin
attenu
salmonella
typhimurium
vaccin
recombin
parapoxviru
vaccin
recombin
orf
viru
orfv
vaccin
recombin
vesicular
stomat
viru
vsv
vaccin
moreov
first
commerci
pedv
vaccin
use
us
call
ipe
vaccin
base
truncat
version
pedv
spike
gene
pvek
replicon
vector
deriv
venezuelan
equin
enceph
viru
vaccin
induc
immun
young
pig
two
dose
given
intramuscularli
im
threeweek
interv
significantli
reduc
sever
clinic
sign
diarrhea
reduc
viral
shed
first
hour
go
forward
new
genet
engin
vaccin
import
direct
develop
pedv
futur
current
adenoviru
vector
system
deriv
human
adenovirus
wide
use
develop
newgener
genet
engin
vaccin
show
advantag
vector
easi
construct
high
effici
gene
transfer
propag
high
titer
safeti
strong
induct
humor
mucos
cellular
immun
respons
therefor
recombin
adenoviru
vector
vaccin
promis
approach
develop
new
viral
vaccin
howev
far
toward
promis
vaccin
studi
recombin
adenoviru
vector
vaccin
pedv
underdevelop
therefor
develop
new
pedv
vaccin
base
recombin
adenoviru
vector
need
achiev
object
studi
novel
recombin
adenoviru
express
pedv
protein
gener
immunogen
protect
efficaci
evalu
pig
studi
approv
institut
anim
use
care
committe
lanzhou
veterinari
research
institut
caa
piglet
use
present
studi
human
maintain
biosafeti
laboratori
experi
euthan
end
experi
accord
anim
care
use
protocol
institut
highli
virul
chines
genotyp
giia
pedv
strain
genbank
access
number
isol
laboratori
propag
vero
cell
atcc
previous
describ
adenoviru
vector
system
deriv
human
adenoviru
serotyp
obtain
genecr
biolog
engin
compani
wuhan
china
vero
cell
grown
dulbecco
modifi
eagl
medium
dmem
invitrogen
usa
contain
heatinactiv
fetal
bovin
serum
fb
invitrogen
australia
antibiot
antimycot
unit
penicillin
streptomycin
per
millilit
usa
cultur
cell
obtain
genecr
biolog
engin
compani
wuhan
china
cultur
dmem
invitrogen
usa
heatinactiv
fb
usa
complet
sequenc
gene
pedv
strain
amplifi
sequenc
restrict
enzym
site
afl
ii
introduc
separ
end
respect
gene
along
histag
synthes
sangon
biotech
shanghai
china
synthes
gene
product
encod
protein
vector
invitrogen
usa
digest
afl
ii
ligat
use
dna
ligas
neb
usa
hour
ligat
product
transform
compet
cell
invitrogen
usa
posit
clone
confirm
restrict
enzym
digest
sequenc
correct
recombin
transfer
bacmid
name
cell
seed
cm
dish
corn
usa
place
incub
confluent
cell
monolay
form
transfect
transfer
bacmid
pbhglox
delta
use
transfect
reagent
invitrogen
usa
incub
hour
fresh
growth
medium
contain
dmem
heatinactiv
fb
ad
cell
cultur
continu
daili
observ
cytopath
effect
cpe
cell
show
cpe
cell
cultur
harvest
frozen
thaw
three
time
centrifug
next
passag
adenoviruspedv
recombin
viru
radpedv
three
passag
third
passag
radpedv
purifi
cesium
chlorid
gradient
centrifug
titer
recombin
adenovirus
test
fluoresc
dilut
follow
cell
seed
plate
maintain
humidifi
incub
hour
harvest
recombin
adenovirus
serial
dilut
dmem
invitrogen
usa
mix
well
vortex
confluenc
monolay
cell
wash
pb
usa
serial
dilut
viru
suspens
inocul
two
replic
per
dilut
hour
incub
dmem
invitrogen
usa
heatinactiv
fb
usa
ad
cell
monitor
hour
viral
titer
determin
use
fluoresc
microscop
furthermor
express
level
pedv
gene
radpedv
measur
realtim
fluoresc
quantit
rtpcr
accord
method
use
previou
studi
radpedv
use
infect
cell
cell
harvest
hour
cell
lyse
use
lysi
buffer
thermo
scientif
waltham
contain
proteas
inhibitor
invitrogen
usa
frozenthaw
time
centrifug
collect
rpm
minut
protein
separ
sdspage
transfer
nitrocellulos
membran
constant
voltag
v
hour
blot
block
skim
milk
hour
incub
primari
mous
antihistag
monoclon
antibodi
mab
dilut
abcam
usa
hour
wash
time
minut
per
wash
tbstween
mm
tri
mm
nacl
tween
ph
membran
incub
secondari
horseradish
peroxidas
hrp
label
goat
antimous
igg
antibodi
dilut
abcam
usa
hour
final
membran
wash
visual
use
ecl
chemiluminesc
substrat
reagent
kit
thermo
scientif
usa
twenti
pig
test
seroneg
pedv
commerci
enzymelink
immunosorb
assay
elisa
kit
biovet
canada
obtain
commerci
pig
farm
previou
herd
histori
ped
outbreak
pedv
vaccin
pig
rais
laboratori
anim
facil
lanzhou
veterinari
research
institut
group
pig
hous
differ
room
vaccin
dose
determin
base
previou
publish
studi
pedv
genebas
recombin
viru
vaccin
shown
tabl
piglet
randomli
divid
four
group
five
pig
group
immun
im
pfuml
adblank
pfuml
radpedv
ml
commerci
pedv
inactiv
vaccin
inactiv
viru
genotyp
giib
strain
viru
titer
inactiv
group
immun
im
phosphatebuff
salin
pb
mock
control
pig
first
immun
day
post
vaccin
dpv
receiv
booster
immun
dpv
condit
serum
sampl
group
collect
dpv
antibodi
dpv
evalu
efficaci
radpedv
pig
group
challeng
oral
ml
cellcultur
viru
contain
highli
virul
genotyp
giib
pedv
strain
challeng
fecal
rectal
swab
collect
piglet
test
realtim
pcr
confirm
pedvneg
result
challeng
clinic
sign
pedv
infect
observ
daili
day
clinic
score
fecal
consist
determin
accord
method
previou
studi
follow
normal
pasti
semiliquid
liquid
fecal
sampl
collect
daili
monitor
viru
shed
fece
experi
period
indirect
elisa
base
pedv
protein
approxim
kda
encod
aa
spike
protein
genotyp
gii
pedv
strain
express
recombin
protein
escherichia
coli
laboratori
develop
assess
igg
iga
antibodi
respons
pig
immun
radpedv
brief
concentr
purifi
pedv
protein
use
coat
elisa
plate
corn
usa
incub
sampl
dilut
hour
plate
wash
pbst
time
hrpconjug
goat
antipig
igg
mab
dilut
abcam
usa
hrpconjug
goat
antipig
iga
mab
dilut
abcam
usa
ad
incub
hour
plate
wash
pbst
time
follow
addit
tmb
substrat
incub
minut
stop
solut
ad
absorb
determin
nm
neutral
antibodi
respons
elicit
immun
radpedv
assess
viru
neutral
vn
test
describ
previous
neutral
antibodi
titer
calcul
reciproc
highest
serum
dilut
inhibit
cpe
viral
rna
extract
intestin
content
use
rneasi
mini
kit
qiagen
usa
accord
manufactur
instruct
realtim
pcr
target
pedv
n
gene
perform
describ
previous
statist
analysi
perform
use
spss
softwar
statist
signific
among
differ
experiment
group
determin
use
oneway
anova
tukey
multiplecomparison
test
differ
consid
signific
p
valu
less
protein
gene
highli
virul
chines
genotyp
giia
pedv
strain
amplifi
sequenc
length
complet
code
sequenc
bp
correspond
aa
synthes
protein
gene
contain
restrict
enzym
site
histag
confirm
sequenc
data
shown
recombin
transfer
bacmid
confirm
restrict
enzym
digest
sequenc
data
shown
express
level
recombin
viru
radpedv
assess
vitro
realtim
fluoresc
quantit
rtpcr
result
show
pedv
gene
well
express
high
level
figur
express
pedv
recombin
viru
radpedv
assess
western
blot
assay
result
reveal
kda
protein
band
consist
predict
size
protein
cell
transfect
radpedv
figur
b
specif
protein
band
observ
cell
infect
adblank
alon
figur
b
result
fluoresc
dilut
assay
also
show
recombin
viru
radpedv
could
well
replic
cell
titer
could
reach
pfuml
figur
c
antipedvspecif
igg
iga
antibodi
titer
differ
group
induc
recombin
viru
radpedv
evalu
pig
follow
immun
im
dpv
dpv
indirect
elisa
base
pedv
protein
shown
figur
compar
adblank
pb
group
radpedv
group
commerci
pedv
inactiv
vaccin
group
exhibit
detect
specif
igg
antibodi
titer
initi
dpv
rose
continu
dpv
p
dpv
dpv
dpv
dpv
specif
igg
antibodi
titer
radpedv
group
commerci
vaccin
group
higher
adblank
pb
group
p
meanwhil
specif
igg
antibodi
titer
commerci
inactiv
vaccin
group
slightli
higher
radpedv
group
dpv
signific
differ
p
similarli
shown
figur
b
specif
iga
antibodi
titer
pig
recombin
viru
radpedv
commerci
inactiv
vaccin
group
significantli
higher
pig
adblank
pb
group
dpv
p
signific
differ
radpedv
inactiv
vaccin
group
p
abil
recombin
viru
radpedv
induc
vn
antibodi
pedv
assess
use
vn
test
similar
level
serolog
igg
iga
antibodi
result
vn
test
reveal
immun
im
radpedv
also
elicit
vn
respons
pedv
vaccin
pig
figur
c
meanwhil
vn
respons
detect
pig
adblank
pb
group
figur
c
togeth
result
indic
recombin
viru
radpedv
could
induc
strong
humor
immun
respons
pig
assess
protect
effect
recombin
viru
radpedv
pig
four
group
tabl
challeng
oral
highli
virul
genotyp
giib
pedv
strain
dpv
four
group
pig
appar
healthi
clinic
symptom
oral
challeng
fecal
rectal
swab
collect
piglet
day
post
inocul
dpi
result
realtim
pcr
confirm
piglet
group
pedv
neg
tabl
dpi
typic
clinic
sign
pedv
infect
observ
pig
adblank
group
pig
pb
group
pig
radpedv
inactiv
vaccin
group
develop
clinic
sign
ped
tabl
pig
adblank
pb
group
develop
sever
diarrhea
dpi
respect
euthan
infect
confirm
clinic
symptom
fecal
viral
shed
tabl
pig
radpedv
inactiv
vaccin
group
pedv
posit
develop
clinic
sign
ped
dpi
tabl
final
radpedv
inactiv
vaccin
group
pig
respect
protect
observ
period
notabl
compar
adblank
pb
group
radpedv
inactiv
vaccin
group
display
obvious
delay
viru
shed
clinic
sign
ped
pig
tabl
therefor
radpedv
provid
partial
protect
highli
virul
pedv
challeng
effect
commerci
inactiv
vaccin
recent
year
mani
studi
conduct
pedv
vaccin
includ
pedv
inactivatedkil
vaccin
attenu
vaccin
geneengin
vaccin
howev
date
pedv
commerci
vaccin
complet
prevent
control
pedv
infect
still
necessari
develop
new
vaccin
improv
current
pedv
vaccin
efficaci
current
recombin
live
vector
vaccin
new
hot
research
topic
develop
vaccin
wide
appli
mani
human
anim
vaccin
develop
attempt
recent
work
develop
pedv
vaccin
sever
recombin
live
vector
vaccin
base
pedv
protein
construct
success
recombin
live
vector
vaccin
elicit
protect
immun
pedv
challeng
piglet
demonstr
potenti
recombin
live
vector
vaccin
deliveri
platform
capabl
elicit
passiv
immun
pedv
therefor
studi
recombin
adenoviru
express
spike
protein
genotyp
giia
pedv
construct
success
immunogen
protect
effici
vaccin
candid
evalu
pig
code
sequenc
protein
use
studi
deriv
highli
virul
chines
genotyp
giia
pedv
strain
genbank
access
number
isol
laboratori
propag
vero
cell
strain
high
pathogen
piglet
high
mortal
almost
infect
suckl
piglet
caus
seriou
clinic
diseas
symptom
wateri
diarrhea
antigen
analysi
show
region
especi
within
ntd
highli
homolog
current
field
strain
base
characterist
strain
select
candid
use
develop
novel
pedv
vaccin
although
adenovirusexpress
vector
show
advantag
vector
easi
construct
higher
effici
gene
transfer
higher
titer
strong
induct
humor
mucos
cellular
immun
respons
strong
immun
respons
induc
adenoviru
protein
result
poor
vaccin
efficaci
result
also
found
studi
although
radpedv
could
induc
high
level
specif
antibodi
efficaci
limit
therefor
futur
studi
carri
improv
vaccin
candid
increas
immun
dose
reduc
side
effect
adenoviru
vector
select
appropri
immun
rout
wellknown
fact
antipedvspecif
iga
antibodi
thought
play
import
role
protect
passiv
lactogen
immun
remain
promis
effect
way
protect
neonat
suckl
piglet
enter
diseas
pedv
protect
suckl
piglet
lactogen
immun
depend
gutmammarysiga
axi
result
show
good
correl
level
serum
igg
iga
induc
radpedv
prove
adenoviru
vector
construct
capabl
elicit
humor
immun
protect
pedv
infect
neonat
piglet
howev
next
studi
radpedv
use
immun
pregnant
sow
determin
whether
produc
siga
antibodi
secret
colostrum
milk
ultim
transfer
suckl
piglet
gutmammarysiga
axi
studi
pig
four
group
challeng
oral
highli
virul
genotyp
giib
pedv
strain
dpv
challeng
typic
clinic
sign
pedv
infect
observ
four
group
dpi
result
demonstr
radpedv
inactiv
vaccin
could
markedli
delay
clinic
sign
reduc
viru
shed
provid
partial
protect
highli
virul
pedv
challeng
possibl
reason
low
protect
efficaci
radpedv
inactiv
vaccin
pig
follow
inocul
dose
pig
challeng
studi
rel
higher
previou
pedv
anim
experi
gener
pedv
anim
experi
use
viru
inoculum
howev
highli
virul
genotyp
giib
pedv
strain
use
inoculum
pig
challeng
studi
although
previou
studi
determin
median
pig
diarrhea
dose
challeng
strain
ml
dpi
experiment
anim
convent
suckl
pig
therefor
challeng
inoculum
dose
present
studi
complet
accord
previou
result
studi
indic
suitabl
inoculum
dose
import
pedv
infect
studi
determin
advanc
variou
age
pig
conclus
present
studi
show
pedv
protein
deriv
emerg
pedv
variant
could
insert
adenoviru
vector
success
express
vitro
anim
studi
show
radpedv
could
induc
high
humor
immun
respons
confer
partial
protect
pig
highli
virul
pedv
challeng
